4:53 PM
 | 
Jan 03, 2014
 |  BC Extra  |  Politics & Policy

U.K. committee calls for more trial transparency

The U.K. Parliament's Public Accounts Committee called on the U.K. Department of Health (DoH) and Medicines and Healthcare products Regulatory Agency (MHRA) to ensure that drug companies register all clinical trials -- both prospectively and retrospectively -- and make full methods and data available to doctors and researchers. In...

Read the full 221 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >